Acceleron Pharma
XLRN
#1821
Rank
NZ$19.98 B
Marketcap
NZ$326.75
Share price
0.00%
Change (1 day)
15,384.34%
Change (1 year)

Earnings for Acceleron Pharma (XLRN)

Earnings in 2021 (TTM): -NZ$0.37 Billion

According to Acceleron Pharma's latest financial reports the company's current earnings are NZ$0.11 Billion. In 2020 the company made an earning of -NZ$0.31 Billion a decrease over its 2019 earnings that were of -NZ$0.25 Billion.

Earnings history for Acceleron Pharma from 2012 to 2021

Annual earnings

Year Earnings Change
2021 (TTM)-NZ$0.37 Billion19.11%
2020-NZ$0.31 Billion22.62%
2019-NZ$0.25 Billion9.67%
2018-NZ$0.23 Billion13.12%
2017-NZ$0.21 Billion92.99%
2016-NZ$0.11 Billion-6.39%
2015-NZ$0.12 Billion20.95%
2014-NZ$92.02 Million154.15%
2013-NZ$36.21 Million-36.22%
2012-NZ$56.77 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
NZ$34.22 B-7,427.52%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$12.73 B-2,827.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$20.20 B-4,425.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
NZ$10.39 B-2,325.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
-NZ$0.21 Billion-56.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
-NZ$33.19 Million-92.89%๐Ÿ‡บ๐Ÿ‡ธ USA
bluebird bio
BLUE
-NZ$0.37 Billion-21.79%๐Ÿ‡บ๐Ÿ‡ธ USA